Cellectar Biosciences Employee Directory

Cellectar Biosciences corporate office is located in 100 Campus Dr Ste 207, Florham Park, New Jersey, 07932, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Operations

4

C-Suite

4

Engineering & Technical

3

Finance

2

Legal

1

Sales

1

Cellectar Biosciences CEO

James Caruso, President, Chief Executive Officer & Director at Cellectar Biosciences
United States flag for contact location.
James CarusoPresident, Chief Executive Officer & Director
PhonePhoneEmailEmail
See Profile

Key Employees of Cellectar Biosciences

  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Cellectar Biosciences Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Cellectar Biosciences

Hundreds of professionals searching for Cellectar Biosciences have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Cellectar Biosciences

Explore people who held key positions, contributed to Cellectar Biosciences's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in New Jersey, United States

Frequently Asked Questions Regarding Cellectar Biosciences Employees

How many employees does Cellectar Biosciences have?
Cellectar Biosciences has 11-50 employees
Who is the CEO of Cellectar Biosciences?
Cellectar Biosciences’s CEO is James Caruso
Who is the CFO of Cellectar Biosciences?
Cellectar Biosciences’s CFO is Chad Kolean
Where is Cellectar Biosciences located?
Cellectar Biosciences’s headquarters are located at 100 Campus Dr Ste 207, Florham Park, New Jersey, 07932, United States
How do I contact Cellectar Biosciences?
Cellectar Biosciences Contact Info: Phone number: (608) 441-8120 Website: www.cellectar.com
What does Cellectar Biosciences do?

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study fo... r patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer.Read More

Is Cellectar Biosciences a public company?
Yes, Cellectar Biosciences is a public company and is traded under the symbol CLRB
See more information about Cellectar Biosciences Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.